Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
Effect of glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors among obese/overweight individuals treated with antipsychotic drug classes: an updated systematic review and meta-analysis of randomized controlled trials
However, because tirzepatide pens often come as single-use auto-injectors (unlike some semaglutide dial-dose pens), the mechanism relies heavily on skin contact to trigger
To be freed from these things releases them from a huge burden, says Dr
When administering the lower dose of Semaglutide at 1 mg to treat patients with diabetes, the SUSTAIN study consistently demonstrated significant improvements in glucose control and body weight reduction 29,30,31,32,33,34,35
By starting with or maintaining lower doses, providers hope to balance effectiveness with tolerability